Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Mills

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Health Technology Assessment (Winchester, England)|June 29, 2022
Sensory integration therapy for children with autism and sensory processing difficulties: the SenITA RCTElizabeth Randell, Melissa Wright, Sarah Milosevic, et al.
Cancer Immunology, Immunotherapy : CII|May 27, 2020
Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapyLaura A Vitale, Li-Zhen He, Lawrence J Thomas, et al.
Allergy|February 20, 2025
Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX-622Michael B Murphy, Laura Vitale, Thomas O'Neill, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Health Technology Assessment (Winchester, England)|June 29, 2022
Sensory integration therapy for children with autism and sensory processing difficulties: the SenITA RCTElizabeth Randell, Melissa Wright, Sarah Milosevic, et al.
Cancer Immunology, Immunotherapy : CII|May 27, 2020
Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapyLaura A Vitale, Li-Zhen He, Lawrence J Thomas, et al.
Allergy|February 20, 2025
Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX-622Michael B Murphy, Laura Vitale, Thomas O'Neill, et al.
Pageof 3